Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 58602-833

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 58602-833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg/60 mg (18 Tablet Carton Label))

Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets 600 mg/60 mg by Aurohealth LLC. The carton shows 18 extended-release tablets for oral use with 12-hour expectorant and nasal decongestant effects. The label includes Drug Facts, warnings, and usage instructions, highlighting relief for nasal and sinus congestion and mucus thinning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.